Your search for "vaccins" return 121 results.
Lagos, July 4, 2018 – Ceva Santé Animale S.A. (“Ceva”), a leader in innovating poultry vaccines, and Olam Hatcheries Limited (“Olam Hatcheries”), a wholly owned subsidiary of Olam International Limite...
Wageningen Bioveterinary Research and Ceva form strategic alliance to counter global threat of emerging and re-emerging diseases >
6 June 2018 - Wageningen Bioveterinary Research (WBVR) and Ceva Santé Animale (Ceva) announced a new collaboration to develop veterinary vaccines for the control of (re)emerging infectious animal dise...
Ceva “Spotlights the Future” at ESPHM2018 Barcelona, demonstrating its strong progress to become one of Europe’s leading suppliers of swine vaccines >
Ceva’s rapid development as a major player in the European swine sector was further underlined with a strong scientific showing during the symposium.
Ceva launches a “new wave of innovation” to help poultry producers meet the performance challenges driven by the need for “No antibiotics” and more sustainable production
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
Marc Prikazsky, Chairman of Ceva, welcomes the Minister of Agriculture and Food and his delegation to the company's Beijing plant.
Ceva details latest poultry “Vaccinology” approach claiming simple vaccination is no longer enough >
At WVPA Congress, Edinburgh, the company outlines its latest innovations, in vaccines, equipment, services and quality certification
The World Veterinary Association (WVA) with Ceva Santé Animale (Ceva) recognize 6 outstanding veterinarians for their commitment to promoting the welfare of Animals
Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >
7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus
Ceva Vaccination Summit details new claims for IB Vaccines.